Grants to support testing of vaccines and treatments for the coronavirus in NAU’s Pathogen and Microbiome Institute (PMI) and disease-intervention modeling in the Center for Health Equity Research (CHER)Continue reading
Author Archive: AZBio
Mask Up Arizona
Wearing a mask when in a public setting, staying a safe distance away from other people, and following CDC recommendations relative disinfecting and personal hygiene can help slow the spread of COVID-19. This is key to improving health and to our economic recovery.
Joan Koerber-Walker, president & CEO, AZBio #MaskUpAZ #MaskUpArizona
All of Us Research Program launches COVID-19 research initiatives
Banner Health and University of Arizona support national data collection effort to shed light on pandemic’s spread and impact
New Report Examines Bioscience Industry’s Economic Impact in Arizona & Role in Global Pandemic
Chandler, Arizona – The Biotechnology Innovation Organization (BIO) released new data on the bioscience industry in the United States. The new report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, analyzes the bioscience industry’s economic footprint across the nation and in Arizona, the significant role of small- and mid-sized companies, and the industry’s response to the COVID-19 pandemic.Continue reading
ICYMI – Great BIO Digital Sessions Available Online
Select Sessions From BIO Digital Week Now Available!Continue reading
Pediatric experts warn against delaying well-child visits
CDC reports drop in recommended child vaccinationsContinue reading
Humabiologics Inc. Reaches $1M Seed Round Funding Milestone
PHOENIX, Ariz.– Humabiologics Inc., a regenerative medicine company founded by scientists and tissue industry experts, announced today it has successfully raised $1 million in seed funding.Continue reading
RCT Acquires Translational Drug Development, LLC
Tucson, Ariz. & Scottsdale, Ariz. / June 4, 2020
Research Corporation Technologies, Inc. (RCT) announced today that it has acquired and invested growth capital into Translational Drug Development (TD2), the leading fully integrated precision oncology medicine development organization.
TD2 provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovative oncology-focused companies.Continue reading
IMNA Announces New Appointment to Its Board Of Directors
IMNA Solutions announced today that it has appointed Russ Yelton, President/CEO of Yelton and Associates and Chairman of The Board of Trustees of AZAdvances to its board of directorsContinue reading